J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.
TL;DR: MeSH Antioxidants /therapeutic use; Biomarkers /blood; Cardiovascular Agents /therapedic use; Card cardiovascular Diseases /blood /drug therapy /enzymology /physiopathology; Endothelium, Vascular /drug effects /metabolism /Physiopathological; Enzyme Inhibitors /TherapeuticUse; Exercise Tolerance; Hemodynamics / drug effects; Humans; Inflammation Mediators /blood
Journal ArticleDOI
Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study
Ioanna Sokoreli,Ioanna Sokoreli,Steffen Pauws,Steffen Pauws,Ewout W. Steyerberg,Ewout W. Steyerberg,Gert-Jan de Vries,Jarno Riistama,Aleksandra Tesanovic,Syed Kazmi,Pierpaolo Pellicori,John G.F. Cleland,John G.F. Cleland,John G.F. Cleland,Andrew L. Clark +14 more
TL;DR: This work investigated the prognostic value of psychosocial factors for predicting first or recurrent events after discharge following hospitalization for heart failure.
Journal ArticleDOI
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Claire E. Welsh,Carlos Celis-Morales,Rosemary Brown,Daniel F. Mackay,James Lewsey,Patrick B. Mark,Stuart R. Gray,Lyn D. Ferguson,Jana Anderson,Donald M. Lyall,John G.F. Cleland,Pardeep S. Jhund,Jason M.R. Gill,Jill P. Pell,Naveed Sattar,Paul Welsh +15 more
TL;DR: In this article, total cholesterol and high-density lipoprotein cholesterol (HDL-C) measurements are central to cardiovascular disease (CVD) risk assessment, but there is continuing debate around the ut...
Journal ArticleDOI
Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL
TL;DR: Reports of the following clinical studies are included: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.
Journal ArticleDOI
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
TL;DR: The prognostic significance of atrial and ventricular arrhythmias, the inherent problems in their diagnosis and whether their presence predicts the risk of sudden deaths and the mode of such deaths in the heart failure population are discussed.